carmustine has been researched along with Ischemic Attack, Transient in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, S | 1 |
| Wang, M | 1 |
| Etu, JJ | 1 |
| Suckow, RF | 1 |
| Cooper, TB | 1 |
| Feinmark, SJ | 1 |
| Bruce, JN | 1 |
| Fine, RL | 1 |
1 other study available for carmustine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue.
Topics: Adenosine; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antineoplastic Agents, Alkyla | 2008 |